Vraylar 1. 5 mg is a widely prescribed medication that has demonstrated promising results in the treatment of various mental health disorders. It belongs to a class of medications known as atypical antipsychotics and contains the active cariprazine substance. This medicine is mainly used to treat schizophrenia and bipolar disorder, providing relief of symptoms such as hallucinations, delusions and mood fluctuations.
According to clinical trials, Vraylar 1. 5 mg has demonstrated efficacy in reducing the positive and negative symptoms of schizophrenia. Patients reported significant improvements in their general wel l-being and in their quality of life after starting to take this medication.
One of the advantages of Vraylar 1. 5 mg is its under sedative effect compared to other antipsychotic drugs. This allows people to remain more alert and occupied throughout the day, minimizing interruptions in their daily routines. In addition, it has demonstrated its potential as a complementary treatment of the major depressive disorder (TDM) when taken together with an antidepressant.
- Vraylar 1. 5 mg belongs to the class of atypical antipsychotic medications.
- It contains cariprazine as an active substance.
- It is mainly used for the treatment of schizophrenia and bipolar disorder.
- Reduce positive and negative symptoms of schizophrenia.
- Under sedative effect compared to other antipsychotic drugs.
- Possible complementary treatment of major depressive disorder.
